- Home
- RVSB vs ANVS Comparison
RVSB vs ANVS Comparison
Compare RVSB & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVSB
- ANVS
- Stock Information
- Founded
- RVSB 1923
- ANVS 2008
- Country
- RVSB United States
- ANVS United States
- Employees
- RVSB N/A
- ANVS N/A
- Industry
- RVSB Savings Institutions
- ANVS Biotechnology: Pharmaceutical Preparations
- Sector
- RVSB Finance
- ANVS Health Care
- Exchange
- RVSB Nasdaq
- ANVS Nasdaq
- Market Cap
- RVSB 99.6M
- ANVS 110.4M
- IPO Year
- RVSB 1993
- ANVS 2020
- Fundamental
- Price
- RVSB $4.74
- ANVS $9.64
- Analyst Decision
- RVSB
- ANVS Strong Buy
- Analyst Count
- RVSB 0
- ANVS 6
- Target Price
- RVSB N/A
- ANVS $29.67
- AVG Volume (30 Days)
- RVSB 17.9K
- ANVS 341.4K
- Earning Date
- RVSB 10-24-2024
- ANVS 11-06-2024
- Dividend Yield
- RVSB 1.70%
- ANVS N/A
- EPS Growth
- RVSB N/A
- ANVS N/A
- EPS
- RVSB 0.05
- ANVS N/A
- Revenue
- RVSB $46,297,000.00
- ANVS N/A
- Revenue This Year
- RVSB N/A
- ANVS N/A
- Revenue Next Year
- RVSB $12.93
- ANVS N/A
- P/E Ratio
- RVSB $98.52
- ANVS N/A
- Revenue Growth
- RVSB N/A
- ANVS N/A
- 52 Week Low
- RVSB $3.30
- ANVS $4.53
- 52 Week High
- RVSB $6.57
- ANVS $22.49
- Technical
- Relative Strength Index (RSI)
- RVSB 51.94
- ANVS 58.70
- Support Level
- RVSB $4.45
- ANVS $9.00
- Resistance Level
- RVSB $4.72
- ANVS $10.54
- Average True Range (ATR)
- RVSB 0.12
- ANVS 0.81
- MACD
- RVSB -0.00
- ANVS 0.12
- Stochastic Oscillator
- RVSB 61.43
- ANVS 74.57
About RVSB Riverview Bancorp Inc
Riverview Bancorp Inc is an American savings and loan holding company. The company through its subsidiaries engages in the business of attracting deposits and puts it to use in its market area to originate commercial business. It is organized into two operating segments, Banking Operations performed by the bank and trust and Investment Services performed by the Trust company. The company products and services include checking, saving, money market, mortgage, home equity, consumer, online banking, cash management, and others.
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for advanced AD.